Sunosi Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
15:08
Mar 09
Andrew Huberman Professor of Neurobiology and Ophthalmology, Stanford Unive… a16z
Sunosi to gain popularity for focus.
Sunosi is FDA-approved for excessive daytime sleepiness and did well in an ADHD trial. It has a gentler arc of alertness and focus because it also hits serotonin slightly, unlike pure stimulants. It will become far more popular soon.
Sunosi 1ST
HIGH

About Sunosi Investor Commentary

Across the available history and selected sources, Buzzberg tracks Sunosi across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Andrew Huberman.